Assignee
CHS PHARMA INC
US·8 granted patents·1 pending application·9 citations·filing 2013–2021
Top patents by PatentIndex Score
9 records- 0187US10272063B2Treatment for ischemic strokeCHS PHARMA INC·Filed 2017·Granted Apr 30, 2019·3 cites·11 claims
- 0287US9827220B2Treatment for ischemic strokeCHS PHARMA INC·Filed 2015·Granted Nov 28, 2017·4 cites·12 claims
- 0377US9050305B2Treatment for ischemic strokeCHS PHARMA INC·Filed 2013·Granted Jun 9, 2015·1 cites·7 claims
- 0471US10945986B2Treatment for ischemic strokeCHS PHARMA INC·Filed 2019·Granted Mar 16, 2021·0 cites·7 claims
- 0569US8871971B2Protection of normal cellsCHS PHARMA INC·Filed 2013·Granted Oct 28, 2014·1 cites·2 claims
- 0658US11576945B2Treatment for ischemic strokeCHS PHARMA INC·Filed 2021·Granted Feb 14, 2023·0 cites·8 claims
- 0755US12246074B2Granulocyte colony-stimulating factor (GCSF) gene therapy for treating neurological diseasesCHS PHARMA INC·Filed 2020·Granted Mar 11, 2025·0 cites·9 claims
- 0842US2017143653A1Use of sulindac for protecting retinal pigment epithelial cells against oxidative stressCHS PHARMA INC·Filed 2017·Application pending·0 cites
- 0941US10792260B2Retinopathy treatmentCHS PHARMA INC·Filed 2015·Granted Oct 6, 2020·0 cites·11 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →